News

This study is the first to assess the efficacy of this drug combination in a real-world setting.

Where does CBT stand today, nearly 60 years after its inception?

Is adult ADHD validated by research? These authors think not.

A psychiatrist shares her first-hand experience with the landmark case of Held v State of Montana.

A time of year to celebrate and protect mental health.

The FDA has released a draft guide to offer their perspective and thoughts on the development of treatments for stimulant use disorder.

What is the risk of diabetes, hypertension, or hyperlipidemia with antipsychotic polypharmacy in patients with schizophrenia? Researchers investigated these associations in a population-based prospective cohort study.

ADHD in adults lead to educational, occupational, relational, and judgment impairments.

Psychiatry will be needed to help heal the mental wounds in the Mideast.

A psychiatrist reflects on blue fortitude as he visits the Columbine Memorial.

Elizabeth Lowenhaupt, MD, CCHP, shares her insights and experiences on correctional psychiatry and juvenile mental health as she looks toward the future of the field.

From new research on treatment-resistant major depression to strategies for supporting trauma-affected refugee youth, here are highlights from the week in Psychiatric Times.

What is new in research on depression?

Does psychiatry’s future lean towards online practice?

Searching for those rare rainbows…

“Over 32 weeks of follow-up, the percentage of patients with remission, the percentage of patients with a treatment response, and the change in the MADRS score from baseline favored esketamine nasal spray.”

The investigators also concluded that depression screening alone may not be sufficient to effectively identify suicide risk.

Does telepsychiatry lessen the therapeutic alliance?

Experiences of awe—have you had one?

Look through the eyes of a medical health care team in a refugee camp with a focus on children’s mental health.

Get ready for our upcoming virtual, interactive conference with some highlights from 2022.

Avoiding hubris: connections between the unsinkable ship and psychiatry.

Is psilocybin a viable treatment for MDD? Researchers performed a phase 2, double blind trial of single-dose psilocybin in patients with treatment resistant depression.

What application do Gandhi’s teachings have in psychiatry?

The experts weighed in on a wide variety of psychiatric issues for the September 2023 issue of Psychiatric Times.

From connections between cannabis use and schizophrenia to some non-psychiatric medications that may worsen symptoms of major depression, here are highlights from the week in Psychiatric Times.

Here are some updates from the world of psychiatry throughout the month of September.

What is new in research on sleep?

Do you have any recent experiences of awe?